A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children
NCT00583609
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Constipation
Interventions
DRUG:
PEG3350
Sponsor
Braintree Laboratories